Kneat.com Inc (KSI-X)
CVE:KSI
4.25
0.19
(4.68%) 1d
Financials
Technical Analysis
Buy, Sell or Hold?
Related posts
Nervous markets await NvidiaThis summary was created by AI, based on 1 opinions in the last 12 months.
Kneat.com Inc (KSI-X) is strategically repositioning itself within the biopharma sector by offering robust validation software, a move that has garnered positive attention from experts. The company has made significant investments in research and development, which initially led to losses, but it is now on the path to profitability. As Kneat secures clients, they anticipate a gradual rollout that promises sustainable growth. The company’s chart indicates strong potential, especially as they are expected to improve their profit margins swiftly in the coming years. Overall, the outlook appears optimistic as they continue to innovate and expand their market presence.
They bring validation software to biopharma, and they do it well. The chart is strong. He's been adding shares. Before, they were losing as they invested in R&D, but now they're becoming profitable. He expects margins to expand quickly in coming years. When they win a client, it takes time to roll out that client. Growth is safe.
Software company that is based in Ireland.
Offers compliance and validation software in life sciences business.
Currently has 8/10 of top pharma & 18/20 top bio-pharma companies as customers.
Growing customer base at a rapid rate.
Very positive on outlook of business.
Will continue to own shares.
- «
- ‹
- 1
- ›
- »
Kneat.com Inc(KSI-X) Rating
Ranking : 3 out of 5
Bullish - Buy Signals / Votes : 1
Neutral - Hold Signals / Votes : 1
Bearish - Sell Signals / Votes : 1
Total Signals / Votes : 3
Kneat.com Inc(KSI-X) Frequently Asked Questions
What is Kneat.com Inc stock symbol?
Kneat.com Inc is a Canadian stock, trading under the symbol KSI-X on the TSX Venture Exchange (KSI-CV). It is usually referred to as TSXV:KSI or KSI-X
Is Kneat.com Inc a buy or a sell?
In the last year, 3 stock analysts published opinions about KSI-X. 1 analyst recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Kneat.com Inc.
Is Kneat.com Inc a good investment or a top pick?
Kneat.com Inc was recommended as a Top Pick by on . Read the latest stock experts ratings for Kneat.com Inc.
Why is Kneat.com Inc stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
Is Kneat.com Inc worth watching?
3 stock analysts on Stockchase covered Kneat.com Inc In the last year. It is a trending stock that is worth watching.
What is Kneat.com Inc stock price?
On 2021-11-12, Kneat.com Inc (KSI-X) stock closed at a price of $4.25.
Rare to find a high-quality, small-cap tech company in Canada with good management. High growth. Grew ARR last quarter by 60%, very impressive. Valuation of 7x may seem high by Canadian standards, but not compared to US peers. Targeting regulated industries that need a validation solution. No dividend.
(Analysts’ price target is $8.35)Has the majority of the big-pharma household names as customers. Delivered on what they said they would over the years. Still quite a bit to go. Selling to both new customers and current installed base, a very good sign. Likes the metrics, management, the market, customer base.